MOS vs NTR: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
NTR is the larger of the two ($33.84B market cap): the incumbent the market prices for continued execution (13.97x forward earnings, beta 1.13). MOS is the smaller challenger ($7.04B), priced similarly on forward earnings (15.30x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
MOS vs NTR: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | MOS | NTR | What it tells you |
|---|---|---|---|
| Market cap | $7.04B | $33.84B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 15.30 | 13.97 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 0.86 | 1.13 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 34% of range | 55% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.62 | 1.32 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how MOS and NTR affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MOS and NTR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MOS and NTR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does The Mosaic Company (MOS) do?
The Mosaic Company is a leading global producer and marketer of concentrated phosphate and potash, the two primary crop nutrients it mines, processes, and distributes to farmers and dealers worldwide. Its business runs across three reporting segments: Phosphates (finished phosphate fertilizers plus premium products like MicroEssentials), Potash (potassium fertilizer from mines in Saskatchewan, New Mexico, and elsewhere), and Mosaic Fertilizantes, a large Brazil-based production and distribution arm that now drives roughly a third of the company's business. Mosaic sells into agriculture, where nutrient demand is tied to planted acreage, crop prices, and farmer economics.
What does Nutrien (NTR) do?
Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. dollars. The company runs four segments: Retail (Nutrien Ag Solutions), which distributes crop nutrients, crop protection, seed and services to farmers through a large network of stores across North America, South America and Australia, plus three upstream segments (Potash, Nitrogen and Phosphate) that mine and manufacture the fertilizers themselves. Nutrien is the largest potash producer in the world by capacity and one of the largest nitrogen producers, so its upstream results move directly with global fertilizer benchmarks, while Retail earns more stable margins from proprietary products and services.
MOS vs NTR: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- MOS drivers: Global crop-nutrient demand; Potash and Esterhazy productivity.
- NTR drivers: Potash pricing and record volumes; Nitrogen leverage to natural gas.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Mosaic is a cyclical commodity producer, so its earnings can swing dramatically with potash and phosphate prices and are exposed to sharp input-cost inflation in sulfur, ammonia, and natural gas. For NTR, the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue.
MOS or NTR: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MOS if you believe its drivers more; NTR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MOS and NTR guides.
MOS vs NTR: the full fundamentals
MOS. Mosaic trades at about ~0.5x sales and ~0.5x book value, levels typical of a commodity producer near a cyclical low, and the trailing P/E is not meaningful because of the ~$639 million trailing loss. The ~12x forward multiple assumes earnings recover toward ~$1.52 per share in 2027. The ~$26 average analyst target sits well above the October 16 close, but several targets were cut in October 2026 as input-cost pressure persisted.
NTR. As of October 16, 2026 NTR trades near $70.61 for a market cap of roughly $33.7 billion, at a trailing P/E around 14.3, a forward P/E near 14.1 and about 8 times EBITDA, modest multiples typical of a cyclical commodity producer. The business is seasonal, with the spring planting quarter usually the strongest (about $10.6 billion of revenue in Q2 2026 versus about $5.8 billion in Q1), and analysts expect 2027 EPS near $5.03, roughly flat on 2026. Because so much of the profit is commodity-driven, valuation multiples on trailing earnings can look cheap near cycle peaks and expensive near troughs, so context on where fertilizer prices sit matters more than the headline P/E.
Headline figures (approximate, October 2026): MOS shows revenue (ttm) ~$12.25 billion, q2 2026 revenue ~$2.82 billion (down ~6% YoY), net income (ttm) ~$639 million net loss, forward p/e ~12x (trailing not meaningful); NTR shows share price / market cap ~$70.61 / ~$33.7 billion (Oct 16, 2026), revenue (ttm) ~$27.3 billion, q2 2026 revenue / net earnings ~$10.6 billion (+4% YoY) / ~$1.21 billion, net earnings / eps (ttm) ~$2.38 billion / ~$4.94.
The bottom line: MOS vs NTR
MOS and NTR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MOS and NTR exposure against your real portfolio. It is not an investment adviser.
Wondering how MOS or NTR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about The Mosaic Company
Ask Walnut's AI anything about MOS and see how it fits what you own.
FAQ
What is the difference between MOS and NTR?
+
The Mosaic Company is a leading global producer and marketer of concentrated phosphate and potash, the two primary crop nutrients it mines, processes, and distributes to farmers and dealers worldwide. Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is MOS or NTR the better stock?
+
Neither is universally better. NTR is the larger incumbent; MOS is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, MOS or NTR?
+
On forward P/E (as of November 2026), MOS trades at 15.30x and NTR at 13.97x, so NTR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both MOS and NTR?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of MOS vs NTR?
+
MOS: Mosaic is a cyclical commodity producer, so its earnings can swing dramatically with potash and phosphate prices and are exposed to sharp input-cost inflation in sulfur, ammonia, and natural gas. In 2026 rising input costs pushed the company to net losses in the first and second quarters, forced temporary curtailments at U.S. phosphate plants and idled some Brazilian SSP output, and it withdrew full-year phosphate production guidance. Cash strain is now a live issue: trailing free cash flow is about ~-$746 million, cash sits near ~$294 million against ~$6.1 billion of debt, and the ~$0.88 annual dividend is no longer covered by GAAP earnings. Global competition is intense, with OCP Group in phosphates and Belarusian and Russian producers in potash affecting prices and supply. Weather, weak farm economics, trade policy, currency moves (especially the Brazilian real), and regulatory or environmental costs at mining and processing sites add further volatility. NTR: The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Natural gas cost spikes would squeeze nitrogen margins, and weather, crop prices and farmer income drive demand for both fertilizer and Retail products in ways Nutrien cannot control. Geopolitics matters heavily, since sanctions, tariffs and shifts in Russian and Belarusian potash supply move global benchmarks. Foreign-exchange swings (the company operates globally but reports in USD) and heavy capital spending on mines and plants add further variability. Finally, the fertilizer industry is concentrated and has faced antitrust and price-fixing litigation, an overhang for the whole peer group. Two nearer-term points stand out as of October 2026. Nutrien has missed consensus EPS in each of the last three reported quarters, by small amounts, and analysts expect third-quarter revenue to fall about 15% year over year with full-year 2027 earnings roughly flat. The balance sheet also carries about $12.7 billion of debt against under $1 billion of cash, manageable at today's cash flows (about $4.2 billion of trailing operating cash flow) but a constraint if a fertilizer downturn arrives.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MOS or NTR; figures are approximate and dated (as of November 2026). Verify current data before investing.